Skip to main content
. Author manuscript; available in PMC: 2014 Jun 15.
Published in final edited form as: Biochem Pharmacol. 2013 Apr 10;85(12):1803–1815. doi: 10.1016/j.bcp.2013.04.004

Table 5.

Affinity of substituted methcathinones and standard compounds at h5-HT1A, h5-HT2A and h5-HT2C receptors.

Inhibition of radioligand binding Ki ± sem (µM) (n)
Drug h5-HT1A
[3H]8OH-DPAT
h5-HT2A
[125I]DOI
h5-HT2C
[125I]DOI
Butylone >96# (3) 118 ± 17(3) 41 ± 12(3)
4-FMC 71.6 ± 3.4(3) 10.0 ± 1.0(3) 12.6 ± 2.4(4)
MDPV 14.8 ± 3.8(3) 207 ± 29 (3) 107 ± 30(3)
Mephedrone >91# (3) 9.0 ± 1.5(4) 9.1 ± 2.1(4)
Methylone 63.28 ± 0.98 (3) 48.5 ± 8.0 (3) 10.6 ± 1.8(3)
Naphyrone 4.64 ± 0.60 (4) 17.7 ± 2.6(4) 23.2 ± 6.4 (3)
METH 5.90 ± 0.85 (3) 43.5 ± 9.1 (4) 10.2 ± 2.9(9)
MDMA 14.1 ± 2.4(5) 8.3 ± 1.2 (4) 1.36 ± 0.44(6)
Methcathinone 29.1 ± 3.6(4) 29.2 ± 3.3 (4) 16.0 ± 4.2 (4)
5-HT 0.00304 ± 0.00053(6) 0.0076 ± 0.0013(10) 0.00170 ± 0.00054(7)
LSD 0.00132 ± 0.00032(10) 0.000148 ± 0.000030(4) 0.00129 ± 0.00016(3)
WAY 100,635 0.000161 ± 0.000040(3)
Ketanserin 0.0156 ± 0.0048(4)
SB242084 0.00247 ± 0.00050(8)

(n) Number of independent experiments conducted in duplicate.

#

If some experiments yielded Ki values less than 100 µM and other experiments yielded Ki values greater than 100 µM, the latter experiments were assigned a value of 100 µM and averages calculated. The actual value is greater than that average and no standard error is reported.

Binding Hill slopes for [3H]8-OH-DPAT ranged from −0.59 to −1.04, for h5-HT2A [125I]DOI ranged from −0.85 to −1.17, and for h5-HT2C [125I]DOI ranged from −0.65 to −1.46.

HHS Vulnerability Disclosure